Almatica is focused on the development, acquisition and commercialization of branded prescription products. The US portfolio covers a wide range of therapeutic areas including: psychiatry, pain management, anti-infectives and cardiovascular related disorders.
Almatica is actively pursuing the expansion of its US product portfolio through the development of its own product pipeline and through the in-licensing and acquisition of products that are either marketed or in late-stage development. The growth of our business is supported by a broad range of in-house commercial, manufacturing, R&D marketing and national sales capabilities.
Alvogen Core Businesses include
Almatica brand products
Focusing on branded pharmaceutical products
Alvogen generic business
Focusing on generic pharmaceutical products for the United States, Europe, Asia and Latin America
Focusing in the commercialization of generic injectable pharmaceuticals for the acute and alternate site healthcare markets in the US
Norwich US-based manufacturing
In-house manufacturing capabilities include finished dosage form including solid oral dosage, soft gelatin capsules, modified release tablets, transdermals, creams, ointments and injectables.